Tarsus Pharmaceuticals is expanding its pipeline to target meibomian gland disease and rosacea, with promising Phase 2 ...

Clarity Pharmaceuticals Ltd ( ASX:CU6 ) is possibly approaching a major achievement in its business, so we would ...

New drug discovery is extremely inefficient. Estimates of the average R&D cost per new drug are less than $1 billion to more ...

Despite its government spending more than any other on health care both per capita and as a percentage of GDP, spending over $4.5 trillion in 2022, the United States has the lowest life expectancy at ...

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, ...

California Gov. Gavin Newsom will soon decide whether the most populous U.S. state will join 25 others in regulating the ...

Effective provider segmentation can make or break a new drug launch, and can also improve the lifecycle of existing portfolio ...

Yakubison discusses his role at Merck & Co., Inc., Rahway, NJ, USA (hereinafter “MSD”), the evolution of pharmaceutical ...

The Indian Pharmaceutical industry is ranked third in pharmaceutical production by volume, having grown at a CAGR of 9.43 percent over the past nine years. According to IBEF, the industry is ...

Let’s take a look at the history of illegal and fraudulent dealings by players in the pharmaceutical industry; an industry that has way more power and influence than we give them credit for.